Simvastatin enhances hepatic nitric oxide production and decreases the hepatic vascular tone in patients with cirrhosis
- 1 March 2004
- journal article
- clinical trial
- Published by Elsevier BV in Gastroenterology
- Vol. 126 (3), 749-755
- https://doi.org/10.1053/j.gastro.2003.12.007
Abstract
No abstract availableKeywords
This publication has 48 references indexed in Scilit:
- “A la carte” treatment of portal hypertension: Adapting medical therapy to hemodynamic response for the prevention of bleedingJournal of Hepatology, 2002
- Direct in vivo evidence of a vascular statin: a single dose of cerivastatin rapidly increases vascular endothelial responsiveness in healthy normocholesterolaemic subjectsBritish Journal of Clinical Pharmacology, 2002
- ACC/AHA/NHLBI Clinical Advisory on the Use and Safety of StatinsStroke, 2002
- Caveolin-1 in normal and cirrhotic human liverGastroenterology, 2000
- Endothelial dysfunction and decreased production of nitric oxide in the intrahepatic microcirculation of cirrhotic ratsJournal of Hepatology, 1998
- Octreotide prevents postprandial splanchnic hyperemia in patients with portal hypertensionJournal of Hepatology, 1994
- Postprandial changes in portal haemodynamics in patients with cirrhosis.Gut, 1992
- Long-term haemodynamic effects of isosorbide 5-mononitrate in patients with cirrhosis and portal hypertensionJournal of Hepatology, 1990
- Postprandial hemodynamic responses in patients with cirrhosisJournal of Hepatology, 1988
- Reduction of the increased portal vascular resistance of the isolated perfused cirrhotic rat liver by vasodilatorsJournal of Hepatology, 1985